Dystonia Therapeutics - Pipeline Assessment and Market Forecasts to 2018
NEW YORK, Dec. 28, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Dystonia Therapeutics - Pipeline Assessment and Market Forecasts to 2018
http://www.reportlinker.com/p0704124/Dystonia-Therapeutics---Pipeline-Assessment-and-Market-Forecasts-to-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy
Dystonia Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Summary
GlobalData, the industry analysis specialist, has released its new report, "Dystonia Therapeutics - Pipeline Assessment and Market Forecasts to 2018". The report is an essential source of information and analysis on the global Dystonia Therapeutics market. The report identifies the key trends shaping and driving the global Dystonia Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Dystonia Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
The report provides information on the key drivers and challenges of the Dystonia Therapeutics market. Its scope includes -
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Dystonia Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2018.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
- Analysis of the current and future competition in the seven key countries Dystonia Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Dystonia Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Dystonia Therapeutics market
Reasons to buy
The report will enhance your decision making capability. It will allow you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Dystonia Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Dystonia Therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What's the next big thing in the global Dystonia Therapeutics market landscape? – Identify, understand and capitalize.
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Dystonia Therapeutics - Introduction 6
2.1 Disease Overview 6
2.1.1 Classification of Dystonia 6
2.2 Epidemiology 9
2.2.1 Quality of Life Parameters 10
2.3 Pathophysiology 10
2.3.1 Clinical Features 10
2.4 Diagnosis 11
2.5 Treatment and Management Options 12
2.6 Referral Pathway 13
2.7 GlobalData Pipeline Report Guidance 14
3 Dystonia Therapeutics - Market Characterization 15
3.1 Overview 15
3.2 Dystonia Therapeutics Market Size (2005-2010) - Global 15
3.3 Dystonia Therapeutics Market Forecast (2010-2018) - Global 16
3.4 Dystonia Therapeutics Market Size (2005-2010) - The US 17
3.5 Dystonia Therapeutics Market Forecast (2010-2018) - The US 18
3.6 Dystonia Therapeutics Market Size (2005-2010) - France 19
3.7 Dystonia Therapeutics Market Forecast (2010-2018) - France 20
3.8 Dystonia Therapeutics Market Size (2005-2010) - Germany 21
3.9 Dystonia Therapeutics Market Forecast (2010-2018) - Germany 22
3.10 Dystonia Therapeutics Market Size (2005-2010) - Italy 23
3.11 Dystonia Therapeutics Market Forecast (2010-2018) - Italy 24
3.12 Dystonia Therapeutics Market Size (2005-2010) - Spain 25
3.13 Dystonia Therapeutics Market Forecast (2010-2018) - Spain 26
3.14 Dystonia Therapeutics Market Size (2005-2010) - The UK 27
3.15 Dystonia Therapeutics Market Forecast (2010-2018) - The UK 28
3.16 Dystonia Therapeutics Market Size (2005-2010) - Japan 29
3.17 Dystonia Therapeutics Market Forecast (2010-2018) - Japan 30
3.18 Drivers and Barriers for the Dystonia Therapeutics Market 31
3.18.1 Drivers for the Dystonia Therapeutics Market 31
3.18.2 Barriers for the Dystonia Therapeutics Market 31
3.19 Opportunity and Unmet Need Analysis 32
3.20 Key Takeaway 33
4 Dystonia Therapeutics - Competitive Assessment 34
4.1 Overview 34
4.2 Strategic Competitor Assessment 34
4.3 Product Profiles for the Major Marketed Products in the Dystonia Market 35
4.3.1 Botox (onabotulinumtoxinA/Botulinum Toxin Type A) 35
4.3.2 Xeomin (OncobotulinumtoxinA) 37
4.3.3 Myobloc (RimabotulinumtoxinB) 38
4.3.4 Dysport (abobotulinumtoxinA) 39
4.4 Key Takeaway 40
5 Dystonia Therapeutics - Pipeline Assessment 41
5.1 Overview 41
5.2 Strategic Pipeline Assessment 41
5.3 Dystonia Therapeutics Pipeline - Pipeline by Phases of Development 41
5.3.1 Dystonia Therapeutics - Phase III Pipeline 41
5.3.2 Dystonia Therapeutics - Phase II Pipeline 42
5.3.3 Dystonia Therapeutics - Phase I/Phase II Pipeline 42
5.3.4 Dystonia Therapeutics - Phase I Pipeline 42
5.3.5 Dystonia Market - Discovery and Pre-Clinical Pipeline 42
5.4 Dystonia Therapeutics Market - Pipeline by Mechanism of Action 43
5.5 Technology Trends Analytic Framework 44
5.6 Molecule Profile for Drugs Under Phase III Development 46
5.6.1 Dysport RU 46
5.7 Key Takeaway 46
6 Dystonia Therapeutics - Clinical Trials Mapping 47
6.1 Clinical Trials by Region/Country (the US, EU5 and Japan) 47
6.2 Clinical Trials by Phase 48
6.3 Clinical Trials by Trial Status 49
6.4 Prominent Sponsors 50
6.5 Top Companies Participating in Dystonia Therapeutics Clinical Trials 52
7 Strategic Assessment 53
7.1 Key Events Impacting the Future Market 53
7.2 Dystonia Therapeutics: Implications for Future Market Competition 54
8 Dystonia Therapeutics - Future Players 55
8.1 Introduction 55
8.2 Company Profiles 56
8.2.1 Ipsen S.A. 56
9 Dystonia Therapeutics - Appendix 57
9.1 Market Definitions 57
9.2 Abbreviations 57
9.3 Methodology 58
9.3.1 Coverage 58
9.3.2 Secondary Research 58
9.3.3 Forecasting 59
9.3.4 Primary Research 62
9.3.5 Expert Panel Validation 62
9.4 Contact Us 62
9.5 Disclaimer 62
9.6 Bibliography 63
List of Tables
Table 1: Classification of Genetic Dystonia 8
Table 2: Physical Signs observed in Patients with Dystonia 10
Table 3: Drugs used for Dystonia 12
Table 4: Dystonia Therapeutics Market, Global, Revenue ($m), 2005-2010 15
Table 5: Dystonia Therapeutics Market, Global, Forecast ($m), 2010-2018 16
Table 6: Dystonia Therapeutics Market, The US, Revenue ($m), 2005-2010 17
Table 7: Dystonia Therapeutics Market, The US, Forecast ($m), 2010-2018 18
Table 8: Dystonia Therapeutics Market, France, Revenue ($m), 2005-2010 19
Table 9: Dystonia Therapeutics Market, France, Forecast ($m), 2010-2018 20
Table 10: Dystonia Therapeutics Market, Germany, Revenue ($m), 2005-2010 21
Table 11: Dystonia Therapeutics Market, Germany, Forecast ($m), 2010-2018 22
Table 12: Dystonia Therapeutics Market, Italy, Revenue ($m), 2005-2010 23
Table 13: Dystonia Therapeutics Market, Italy, Forecast ($m), 2010-2018 24
Table 14: Dystonia Therapeutics Market, Spain, Revenue ($m), 2005-2010 25
Table 15: Dystonia Therapeutics Market, Spain, Forecast ($m), 2010-2018 26
Table 16: Dystonia Therapeutics Market, The UK, Revenue ($m), 2005-2010 27
Table 17: Dystonia Therapeutics Market, The UK, Forecast ($m), 2010-2018 28
Table 18: Dystonia Therapeutics Market, Japan, Revenue ($m), 2005-2010 29
Table 19: Dystonia Therapeutics Market, Japan, Forecast ($m), 2010-2018 30
Table 20: Efficacy Outcomes of the Phase III Cervical Dystonia Study 36
Table 21: Number of Patients Treated per Muscle and Fraction of Total Dose Injected into Involved Muscles 36
Table 22: Dystonia Therapeutics, Phase III Pipeline, 2011 41
Table 23: Dystonia Therapeutics, Phase II Pipeline, 2011 42
Table 24: Dystonia Therapeutics, Phase I/Phase II Pipeline, 2011 42
Table 25: Dystonia Therapeutics, Phase I Pipeline, 2011 42
Table 26: Dystonia Therapeutics, Discovery and Pre-Clinical Pipeline, 2011 42
Table 27: Dystonia Therapeutics, Clinical Trials by Country, 2011 47
Table 28: Dystonia Therapeutics, Clinical Trials by Phase, 2011 48
Table 29: Dystonia Therapeutics, Clinical Trials by Status of Development, 2011 49
Table 30: Dystonia Therapeutics, Prominent Sponsors, 2011 51
Table 31: Dystonia Therapeutics, Top Companies Participating in Therapeutics Clinical Trials, 2011 52
Table 32: Ipsen S.A. -Dystonia Pipeline Products, 2011 56
List of Figures
Figure 1: Classification of Dystonia 7
Figure 2: Dystonia Diagnostic Algorithm 11
Figure 3: Referral Pathway for Dystonia 13
Figure 4: Dystonia Therapeutics Market, Global, Revenue ($m), 2005-2010 15
Figure 5: Dystonia Therapeutics Market, Global, Forecast ($m), 2010-2018 16
Figure 6: Dystonia Therapeutics Market, The US, Revenue ($m), 2005-2010 17
Figure 7: Dystonia Therapeutics Market, The US, Forecast ($m), 2010-2018 18
Figure 8: Dystonia Therapeutics Market, France, Revenue ($m), 2005-2010 19
Figure 9: Dystonia Therapeutics Market, France, Forecast ($m), 2010-2018 20
Figure 10: Dystonia Therapeutics Market, Germany, Revenue ($m), 2005-2010 21
Figure 11: Dystonia Therapeutics Market, Germany, Forecast ($m), 2010-2018 22
Figure 12: Dystonia Therapeutics Market, Italy, Revenue ($m), 2005-2010 23
Figure 13: Dystonia Therapeutics Market, Italy, Forecast ($m), 2010-2018 24
Figure 14: Dystonia Therapeutics Market, Spain, Revenue ($m), 2005-2010 25
Figure 15: Dystonia Therapeutics Market, Spain, Forecast ($m), 2010-2018 26
Figure 16: Dystonia Therapeutics Market, The UK, Revenue ($m), 2005-2010 27
Figure 17: Dystonia Therapeutics Market, The UK, Forecast ($m), 2010-2018 28
Figure 18: Dystonia Therapeutics Market, Japan, Revenue ($m), 2005-2010 29
Figure 19: Dystonia Therapeutics Market, Japan, Forecast ($m), 2010-2018 30
Figure 20: Opportunity and Unmet Need in the Dystonia Therapeutics Market, 2010 33
Figure 21: Dystonia Therapeutics, Strategic Competitor Assessment, 2010 34
Figure 22: Dystonia Therapeutics - Pipeline by Phase of Development, 2011 41
Figure 23: Dystonia Therapeutics, Pipeline by Mechanism of Action (%), 2011 43
Figure 24: Dystonia Therapeutics, Technology Trends Analytics Framework, 2011 44
Figure 25: Dystonia Therapeutics, Technology Trends Analytics Framework, Description, 2011 45
Figure 26: Dystonia Therapeutics, Clinical Trials by Country, 2011 47
Figure 27: Dystonia Therapeutics, Clinical Trials by Phase (%), 2011 48
Figure 28: Dystonia Therapeutics, Clinical Trials by Status of Development (%), 2011 49
Figure 29: Dystonia Therapeutics, Overall Sponsors (%), 2011 50
Figure 30: Dystonia Therapeutics, Prominent Sponsors (%), 2011 51
Figure 31: Dystonia Therapeutics Market, Drivers and Restraints, 2011 53
Figure 32: Implications for Future Market Competition in the Dystonia Market, 2011 54
Figure 33: Dystonia Therapeutics Market, Pipeline by Company, 2011 55
Figure 34: GlobalData Market Forecasting Model 61
Companies mentioned
Ipsen S.A
To order this report:
Therapy Industry: Dystonia Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Check our Industry Analysis and Insights
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article